Abstract

Matched unrelated donors (URD) are the most frequent source of stem cells for allogeneic hematopoietic cell transplantation (HCT) to date, with HCT performed mainly under conventional immunosuppression by methotrexate and cyclosporine. In this setting, every single allelic donor–recipient mismatch for HLA-A, -B, -C, -DRB1 (8/8), but not for HLA-DQB1, -DPB1, has a significant negative effect on overall survival (OS). When several 8/8 HLA-matched URD are available, donor age is the most important factor impacting OS. Moving forward from the traditional way of counting the number of donor–recipient HLA allele mismatches to biology-driven algorithms for functional matching has led to the unraveling of an association between permissive, low-risk HLA-DPB1 mismatches and improved outcome after URD HCT for malignant disease but not for nonmalignant disease. Functional HLA matching might prove to have increasing importance for URD selection in the era of new immunosuppressive regimens that have the potential to substantially reshuffle the role of HLA mismatches in URD HCT.

References

References
1.
Singh
AK
,
McGuirk
JP
.
Allogeneic stem cell transplantation: a historical and scientific overview
.
Cancer Res
.
2016
;
76
(
22
):
6445
-
6451
.
2.
D’Souza
A
,
Fretham
C
. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides, 2018. Center for International Blood and Marrow Transplant Research (CIBMTR). http://www.cibmtr.org. Accessed 30 September 2019.
3.
Gragert
L
,
Eapen
M
,
Williams
E
, et al
.
HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry
.
N Engl J Med
.
2014
;
371
(
4
):
339
-
348
.
4.
Dehn
J
,
Spellman
S
,
Hurley
CK
, et al
.
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from NMDP/CIBMTR
.
Blood
.
2019
;
134
(
12
):
924
-
934
.
5.
Thorsby
E
.
A short history of HLA
.
Tissue Antigens
.
2009
;
74
(
2
):
101
-
116
.
6.
Robinson
J
,
Halliwell
JA
,
Hayhurst
JD
,
Flicek
P
,
Parham
P
,
Marsh
SG
.
The IPD and IMGT/HLA database: allele variant databases
.
Nucleic Acids Res
.
2015
;
43
(
Database issue
):
D423
-
D431
.
7.
Tiercy
JM
.
How to select the best available related or unrelated donor of hematopoietic stem cells?
Haematologica
.
2016
;
101
(
6
):
680
-
687
.
8.
Fleischhauer
K
,
Horn
PA
,
Harmer
A
.
Immunogenetics laboratory
. In:
Gluckman
É
,
Niederwieser
D
,
Aljurf
M
, eds.),
Establishing a Hematopoietic Stem Cell Transplantation Unit: A Practical Guide
.
Cham, Switzerland
:
Springer
;
2018
.
9.
Nunes
E
,
Heslop
H
,
Fernandez-Vina
M
, et al
.
Definitions of histocompatibility typing terms
.
Blood
.
2011
;
118
(
23
):
e180
-
e183
.
10.
Mayor
NP
,
Hayhurst
JD
,
Turner
TR
, et al
.
Recipients receiving better HLA-matched hematopoietic cell transplantation grafts, uncovered by a novel HLA typing method, have superior survival: a retrospective study
.
Biol Blood Marrow Transplant
.
2019
;
25
(
3
):
443
-
450
.
11.
Fleischhauer
K
,
Shaw
BE
.
HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities
.
Blood
.
2017
;
130
(
9
):
1089
-
1096
.
12.
Fleischhauer
K
,
Shaw
BE
,
Gooley
T
, et al
;
International Histocompatibility Working Group in Hematopoietic Cell Transplantation
.
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study
.
Lancet Oncol
.
2012
;
13
(
4
):
366
-
374
.
13.
Petersdorf
EW
,
Malkki
M
,
O’hUigin
C
, et al
.
High HLA-DP expression and graft-versus-host disease
.
N Engl J Med
.
2015
;
373
(
7
):
599
-
609
.
14.
Gratwohl
A
,
Sureda
A
,
Cornelissen
J
, et al
.
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation
.
Leukemia
.
2017
;
31
(
8
):
1752
-
1759
.
15.
Lee
SJ
,
Klein
J
,
Haagenson
M
, et al
.
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
.
Blood
.
2007
;
110
(
13
):
4576
-
4583
.
16.
Fürst
D
,
Müller
C
,
Vucinic
V
, et al
.
High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis
.
Blood
.
2013
;
122
(
18
):
3220
-
3229
.
17.
Kekre
N
,
Mak
KS
,
Stopsack
KH
, et al
.
Impact of HLA-mismatch in unrelated donor hematopoietic stem cell transplantation: a meta-analysis
.
Am J Hematol
.
2016
;
91
(
6
):
551
-
555
.
18.
Morishima
Y
,
Kashiwase
K
,
Matsuo
K
, et al
;
Japan Marrow Donor Program
.
Biological significance of HLA locus matching in unrelated donor bone marrow transplantation
.
Blood
.
2015
;
125
(
7
):
1189
-
1197
.
19.
Ayuk
F
,
Beelen
DW
,
Bornhäuser
M
, et al
.
Relative impact of HLA matching and non-HLA donor characteristics on outcomes of allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
.
Biol Blood Marrow Transplant
.
2018
;
24
(
12
):
2558
-
2567
.
20.
Robinson
TM
,
O’Donnell
PV
,
Fuchs
EJ
,
Luznik
L
.
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide
.
Semin Hematol
.
2016
;
53
(
2
):
90
-
97
.
21.
El Fakih
R
, Hashmi SK,
Ciurea
SO
, et al
.
Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application [published online ahead of print 14 May 2019]
.
Bone Marrow Transplant
.
doi:10.1038/s41409-019-0547-8
.
22.
Pidala
J
,
Lee
SJ
,
Ahn
KW
, et al
.
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation
.
Blood
.
2014
;
124
(
16
):
2596
-
2606
.
23.
Davis
E
,
Devlin
S
,
Cooper
C
, et al
.
Validation of an algorithm to predict the likelihood of an 8/8 HLA-matched unrelated donor at search initiation
.
Biol Blood Marrow Transplant
.
2018
;
24
(
5
):
1057
-
1062
.
24.
Shaw
BE
,
Logan
BR
,
Spellman
SR
, et al
.
Development of an unrelated donor selection score predictive of survival after HCT: donor age matters most
.
Biol Blood Marrow Transplant
.
2018
;
24
(
5
):
1049
-
1056
.
25.
Kollman
C
,
Spellman
SR
,
Zhang
MJ
, et al
.
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
.
Blood
.
2016
;
127
(
2
):
260
-
267
.
26.
Teira
P
,
Battiwalla
M
,
Ramanathan
M
, et al
.
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
.
Blood
.
2016
;
127
(
20
):
2427
-
2438
.
27.
Zhang
YL
,
Zhu
Y
,
Xiao
Q
,
Wang
L
,
Liu
L
,
Luo
XH
.
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies
.
Ann Hematol
.
2019
;
98
(
4
):
1009
-
1020
.
28.
Schmidt-Hieber
M
,
Labopin
M
,
Beelen
D
, et al
.
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
.
Blood
.
2013
;
122
(
19
):
3359
-
3364
.
29.
Wroblewski
EE
,
Parham
P
,
Guethlein
LA
.
Two to tango: co-evolution of hominid natural killer cell receptors and MHC
.
Front Immunol
.
2019
;
10
:
177
.
30.
Boudreau
JE
,
Hsu
KC
.
Natural killer cell education in human health and disease
.
Curr Opin Immunol
.
2018
;
50
:
102
-
111
.
31.
Heidenreich
S
,
Kröger
N
.
Reduction of relapse after unrelated donor stem cell transplantation by KIR-based graft selection
.
Front Immunol
.
2017
;
8
:
41
.
32.
Wagner
I
,
Schefzyk
D
,
Pruschke
J
, et al
.
Allele-level KIR genotyping of more than a million samples: workflow, algorithm, and observations
.
Front Immunol
.
2018
;
9
:
2843
.
33.
Fleischhauer
K
,
Beelen
DW
.
HLA mismatching as a strategy to reduce relapse after alternative donor transplantation
.
Semin Hematol
.
2016
;
53
(
2
):
57
-
64
.
34.
Pidala
J
,
Wang
T
,
Haagenson
M
, et al
.
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality
.
Blood
.
2013
;
122
(
22
):
3651
-
3658
.
35.
Crivello
P
,
Heinold
A
,
Rebmann
V
, et al
.
Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT
.
Blood
.
2016
;
128
(
1
):
120
-
129
.
36.
Fernandez-Vina
MA
,
Klein
JP
,
Haagenson
M
, et al
.
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation
.
Blood
.
2013
;
121
(
22
):
4603
-
4610
.
37.
Lorentino
F
,
Sacchi
N
,
Oldani
E
, et al
.
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation [published online ahead of print 30 August 2019]
.
Haematologica
.
doi:10.3324/haematol.2019.225177
.
38.
Meurer
T
,
Arrieta-Bolaños
E
,
Metzing
M
, et al
.
Dissecting genetic control of HLA-DPB1 expression and its relation to structural mismatch models in hematopoietic stem cell transplantation
.
Front Immunol
.
2018
;
9
:
2236
.
39.
Morishima
S
,
Shiina
T
,
Suzuki
S
, et al
;
Japan Marrow Donor Program
.
Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation
.
Blood
.
2018
;
131
(
7
):
808
-
817
.
40.
Passweg
JR
,
Baldomero
H
,
Basak
GW
, et al
.
The EBMT Activity Survey Report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies [published online ahead of print 6 February 2019]
.
Bone Marrow Transplant
.
doi:10.1038/s41409-019-0465-9
.
You do not currently have access to this content.

Comments

0 Comments